CNO Financial Group (NYSE:CNO) Update / Briefing September 10, 2025 10:00 AM ET Company ParticipantsNathan Richardson - SVP - Sales & DistributionCheryl Heilman - PresidentScott Goldberg - President - Consumer DivisionStephen Janoson - VP - Direct & Independent DistributionAdam Auvil - VP - IR & SustainabilityConference Call ParticipantsSuneet Kamath - Senior Research AnalystWes Carmichael - Senior Analyst - US InsuranceAdam AuvilGood morning and welcome to CNO Financial Group's Investor Briefing focused on ...

Financial Data and Key Metrics Changes - First quarter revenue reached $113.1 million, reflecting a 22% year-over-year growth driven primarily by increased Medicare enrollments [7][24] - GAAP net income was $2 million, a significant improvement from a net loss of $17 million in the previous year [29] - Adjusted EBITDA was $12.5 million compared to a negative $1.7 million in Q1 of 2024, indicating strong profitability growth [29][30] - Cash, cash equivalents, and short-term marketable securities totaled $155.6 million at the end of the quarter, up from $70.8 million last year [31] Business Line Data and Key Metrics Changes - Medicare segment revenue was $103.7 million, a 26% increase year-over-year, with Medicare submissions across agency and Amplify Fulfillment models growing 22% [24][11] - The agency fulfillment model saw submitted Medicare Advantage (MA) applications increase by 26% year-over-year, driven by effective marketing strategies [12] - Medicare non-commission revenue increased by 20% to $13.9 million, primarily due to greater fee-based revenue from Amplify [24] Market Data and Key Metrics Changes - The company reported a 22% growth in total Medicare submissions across fulfillment models, with hybrid enrollments experiencing the strongest growth at 38% year-over-year [11][13] - The final Medicare Advantage carrier reimbursement rates exceeded market expectations, providing relief to the broader Medicare Advantage industry [10] Company Strategy and Development Direction - The company is focused on enhancing its customer-centric choice model, which has become increasingly relevant in a complex Medicare landscape [6] - EHealth aims to maintain its position as a technological leader by integrating artificial intelligence into its telephonic enrollment processes [14] - The company is committed to expanding its brand identity and enhancing the connection between its trusted brand and online consumer platform [13] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding the regulatory environment, noting that the absence of new regulations is encouraging [42] - The company anticipates challenges in year-over-year comparisons due to regulatory changes in Dual Special Needs Plans (DSNP) enrollment rules [19] - Management emphasized the importance of new Medicare enrollments as a key consumer segment for the upcoming quarters [19] Other Important Information - The company is facing a Department of Justice complaint but believes the claims are without merit and intends to challenge them vigorously [20][21] - EHealth's commitment to providing free, unbiased expert advice remains a core part of its mission [21] Q&A Session Summary Question: Impact of Elevance's removal of Medicare Advantage plans from online marketing platforms - Management noted that the macro environment is evolving and emphasized their strategy of having diverse carrier relationships to mitigate dependency on any single carrier [36] Question: Thoughts on the regulatory environment and its impact on operations - Management expressed cautious optimism about the regulatory environment, highlighting the lack of new regulations and the potential for less volatility in the upcoming enrollment season [42][43] Question: Changes in carrier discussions due to DOJ focus - Management indicated it is too early to assess any changes in carrier discussions following the DOJ news, noting that support varies among carriers [51] Question: Update on ancillary services and their impact on retention - Management stated that while ancillary services are still in their infancy, they believe providing additional value can enhance retention, although it currently does not significantly impact revenue [55]

Financial Data and Key Metrics Changes - Operating earnings per diluted share were $0.79, up 52%, and $0.74, up 42% excluding significant items [5][24] - Book value per diluted share, excluding AOCI, was $37.03, up 6% [7] - Capital and liquidity remain well above target levels after returning $117 million to shareholders [6] Business Line Data and Key Metrics Changes - Consumer division saw annuity collected premiums up 12%, account values up 7%, and premium per policy up 19% [10] - Health NAP was up 9%, with Medicare Supplement NAP up 24% and Medicare Advantage policies up 42% [13][14] - Worksite insurance sales were up 11%, with critical illness insurance up 37% and life insurance up 17% [19] Market Data and Key Metrics Changes - New money rates exceeded 6% for nine consecutive quarters [6] - Total investment income was up 16% for the quarter, marking the sixth consecutive quarter of growth [28] - The market value of invested assets grew 11% in the quarter [29] Company Strategy and Development Direction - The company aims to leverage its business model for sustained profitable growth and drive ROE expansion [8] - Focus on reaching the underserved middle-income market remains a key differentiator [9] - Introduction of new products like Optimize Clear to enhance service offerings [22] Management's Comments on Operating Environment and Future Outlook - Management acknowledges deteriorating visibility into macroeconomic drivers but expresses confidence in navigating volatility [7][31] - The company reaffirms its full-year guidance despite a more volatile environment [30] - Long-term commitment to improving run rate ROE by 150 basis points from 2025 to 2027 [31] Other Important Information - The company plans to launch a new series of investor briefings starting in June [34] - Fee income was adversely impacted by ASC 606 revenue recognition accounting [24] Q&A Session Summary Question: On buybacks, will the company lean into buybacks in the current macro environment? - Management indicated a willingness to continue elevated buyback levels due to strong cash flow [37] Question: Can you explain the GAAP accounting revenue recognition for Medicare Advantage? - Management provided details on how revenue recognition differs from cash flow, emphasizing the impact of sales mix on fee income [39][40] Question: What is the outlook for PAC in the Consumer division? - Management expects continued growth in PAC, despite potential quarter-to-quarter fluctuations [66] Question: How does the company view the demand for insurance products in a recession? - Management believes demand for products will remain strong due to demographic trends, despite potential economic downturns [70][71] Question: What are the implications of potential shifts from Medicare Advantage to Medicare Supplement? - Management expressed confidence that any shifts would not materially impact the business, as they can benefit from both product lines [76] Question: Can you elaborate on the geographic expansion in the worksite division? - Management confirmed ongoing disciplined geographic expansion contributing to sales growth [85]